Importantly, knockdown of CDH1 overturned the prohibitive impacts of silencing miR-106a on proliferation, invasion and glycolysis, and the promotion effect on apoptosis in ovarian cancer cells. The gene discussed is CDH1; the disease is ovarian carcinoma.